(Q36654341)

15 August 2017

1 reference

title

Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma (English)

1 reference

15 August 2017

1 reference

Farhad Ravandi

1 reference

15 August 2017

Varsha Gandhi

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

1601-1613

1 reference

The molecular pathology of primary immunodeficiencies

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

The metabolism of deoxyguanosine in mitochondria: a characterization of the phosphorylation process which occurs in intact mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Purine nucleoside phosphorylases: properties, functions, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Crystal structure of human purine nucleoside phosphorylase complexed with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Transition states and inhibitors of the purine nucleoside phosphorylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2′-deoxyguanosine in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Partial purification and characterization of deoxyguanosine kinase from pig skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

Guanine arabinoside as a bone marrow-purging agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1601

10.1517/13543784.15.12.1601

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference